Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials

Journal of Immunological Methods

Volumn 315, Issue 1-2, 2006, Pages 121-132

  Moodie, Zoe ^a   Huang, Yunda ^a   Gu, Lin ^a   Hural, John ^a   Self, Steven G ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

ELISpot; HIV 1 vaccine; Permutation test; Positivity; T lymphocytes

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION CONTROL; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AIDS VACCINES; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33748879767     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.07.015     Document Type: Article

References (37)

1. Altfeld M.A., Trocha A., Eldridge R.L., Rosenberg E.S., Phillips M.N., Addo M.M., Sekaly R.P., Kalams S.A., Burchett S.A., McIntosh K., Walker B.D., and Goulder P.J.R. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. J. Virol. 74 (2000) 8541
2. Costigan T. Bonferroni inequalities and intervals, encyclopedia of biostatistics. In: Armitage P., and Colton T. (Eds). Encyclopedia of Biostatistics (1998), Wiley, New York 421
3. Currier J.R., Kuta E.G., Turk E., Earhart L.B., Loomis-Price L., Janetzki S., Ferrari G., Birx D.L., and Cox J.H. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assay. J. Immunol. Methods 260 1-2 (2002) 157
4. Czerkinsky C., Andersson G., Ekre H.-P., Nilsson L.-Å., Klareskog L., and Ouchterlony Ö. Reverse ELISpot assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods 110 (1988) 29
5. Dudoit S., Shaffer J.P., and Boldrick J.C. Multiple hypothesis testing in microarray experiments. Stat. Sci. 18 (2003) 71
6. ElGhazali G.E.B., Paulie S., Andersson G., Hansson Y., Holmquist G., Olsson T., Ekre H.-P., and Troye-Blomberg M. Number of interleukin-4- and interferon-γ-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation. Eur. J. Immunol. 23 (1993) 2740
7. Eyeson J., King D., Boaz M.J., Sefia E., Tomkins S., Waters A., Easterbrook P.J., and Vyakarnam A. Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects. AIDS 17 16 (2003) 2299 (Nov 7)
8. Gandhi R.T., and Walker B.D. Immunologic control of HIV-1. Annu. Rev. Med. 53 (2002) 149
9. Goulder P.J.R., Brander C., Annamalai K., Mngqundaniso N., Govender U., Tang Y., He S., Hartman K.E., O'Callaghan C.A., Ogg G.S., Altfeld M.A., Rosenberg E.S., Cao H., Kalams S.A., Hammond M., Bunce M., Pelton S.I., Burchett S.A., McIntosh K., Coovadia H.M., and Walker B.D. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and Caucasoid adults and children. J. Virol. 74 (2000) 5679
10. Graham B. Safety and immunogenicity of a multiclade HIV-1 recombinant adenovirus vaccine boost in prior recipients of a HIV-1 DNA vaccine. AIDS Vaccine 2005, Montreal (2005) Abstract No. 14 (827P)
11. Herr W., Protzer U., Lohse A.W., Gerken G., Meyer zum Bueschenfelde K.-H., and Woelfel T. Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure. J. Infect. Dis. 178 (1997) 260
12. Hudgens M.G., Self S.G., Chiu Y.L., Russell N.D., Horton H., and McElrath M.J. Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials. J. Immunol. Methods 288 1-2 (2004) 19 (May)
13. Ihaka R., and Gentleman R. R: a language for data analysis and graphics. J. Comput. Graph. Stat. 5 (1996) 299
14. Isaacs R. Evaluating the efficacy of the Merck adenovirus serotype 5-based trivalent MRKAD5GAG/POL/NEF vaccine. AIDS Vaccine 2005, Montreal (2005) Abstract No. 42
15. Janetzki S., Palla D., Rosenhauer V., Lochs H., Lewis J.J., and Srivastava P.K. Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int. J. Cancer 88 (2000) 232
16. Klausner R.D., Fauci A.S., Corey L., Nabel G.J., Gayle H., Berkley S., Haynes B.F., Baltimore D., Collins C., Douglas R.G., Esparza J., Francis D.P., Ganguly N.K., Gerberding J.L., Johnston M.I., Kazatchkine M.D., McMichael A.J., Makgoba M.W., Pantaleo G., Piot P., Shao Y., Tramont E., Varmus H., and Wasserheit J.N. The need for a global HIV vaccine enterprise. Science 300 5628 (2003) 2036
17. Lechner F., Wong D.K.H., Dunbar P.R., Chapman R., Chung R.T., Dohrenwend P., Robbins G., Phillips R., Klenerman P., and Walker B.D. Analysis of successful immune responses in persons infected with Hepatitis C virus. J. Exp. Med. 191 (2000) 1499
18. Lewis J.J., Janetzki S., Schaed S., Panageas K.S., Wang S., Williams L., Meyers M., Butterworth L., Livingston P.O., Chapman P.B., and Houghton A.N. Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide. Int. J. Cancer 87 3 (2000) 391 (Aug 1)
19. Link H., Olsson O., Sun J., Wang W.-Z., Andersson G., Ekre H.-P., Brenner T., Abramsky O., and Olsson T. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J. Clin. Invest. 87 (1991) 2191
20. Mahanty S., Abrams J.S., King C.L., Limaye A.P., and Nutman T.B. Parallel regulation of IL-4 and IL-5 in human helminth infections. J. Immunol. 148 (1992) 3567
21. Matijevic M., and Urban R.G. Use of interferon-gamma ELISPOT in monitoring immune responses in humans. Methods Mol. Biol. 302 (2005) 237
22. Mogg R., Fan F., Li X., Dubey S., Fu T.-M., Shiver J., and Mehrotra D. Statistical Cross-validation of Merck's IFN-γ ELISpot Assay Positivity Criterion (2003), AIDS Vaccine, New York, NY
23. Moodie Z., Rossini A.J., Hudgens M.G., Gilbert P.B., Self S.G., and Russell N.D. Statistical evaluation of HIV vaccines in early clinical trials. Contemp. Clin. Trials 27 (2006) 147
24. Moss R.B., Webb E., Giermakowska W.K., Jensen F.C., Savary J.R., Wallace M.R., and Nocola D.J.C. HIV-1-specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISpot after treatment with an inactivated, gp120-depleted HIV-1 in Incomplete Freund's adjuvant. J. Acquir. Immune Defic. Syndr. 24 (2000) 264
25. Nagorsen D., Keilholz U., Rivoltini L., Schmittel A., Letsch A., Asemissen A.M., Berger G., Buhr H.-J., Thiel E., and Scheibenbogen C. Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecules, her-2/neu, and carcinoembryogenic antigen in patients with colorectal cancer. Cancer Res. 60 (2000) 4850
26. Olsson T., Zhi W.W., Höjeberg B., Kostulas V., Yu-Ping J., Anderson G., Ekre H.-P., and Link H. Autoreactive T lymphocytes in multiple sclerosis determined by antigen induced secretion of interferon-γ. J. Clin. Invest. 86 (1990) 981
27. Pathan A.A., Wilkinson K.A., Wilkinson R.J., Latif M., McShane H., Pasvol G., Hill A.V.S., and Lalvani A. High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease. Eur. J. Immunol. 30 (2000) 2713
28. Pelfrey C.M., Rudick R.A., Cotleur A.C., Lee J.-C., Tary-Lehmann M., and Lehmann P.V. Quantification of self-recognition in Multiple Sclerosis by single-cell analysis of cytokine production. J. Immunol. 165 (2000) 1641
29. Petrondas D.A., and Gabriel R.K. Multiple comparisons by rerandomization tests. J. Am. Stat. Assoc. 78 (1983) 949
30. Rahman F., Dahmen A., Herzog-Hauff S., Boecher W.O., Galle P.R., and Loehr H.F. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major Hepatitis B surface antigen. Hepatology 31 (2000) 521
31. Rowland-Jones S.L., Dong T., Fowke K.R., Kimani J., Krausa P., Newell H., Blanchard T., Ariyoshi K., Oyugi J., Ngugi E., Bwayo J., MacDonald K.S., McMichael A.J., and Plummer F.A. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J. Clin. Invest. 102 (1998) 1758
32. Russell N.D., Hudgens M.G., Ha R., Havenar-Daughton C., and McElrath M.J. Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. J. Infect. Dis. 187 2 (2003) 226 (Jan 15)
33. Slyker J.A., Lohman B.L., Mbori-Ngacha D.A., Reilly M., Wee E.G., Dong T., McMichael A.J., Rowland-Jones S.L., Hanke T., and John-Stewart G. Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants. Vaccine 23 38 (2005) 4711 (Sep 7)
34. Tassignon J., Burny W., Dahmani S., Zhou L., Stordeur P., Byl B., and De Groote D. Monitoring of cellular responses after vaccination against tetanus toxoid: comparison of the measurement of IFN-gamma production by ELISA, ELISpot, flow cytometry and real-time PCR. J. Immunol. Methods 305 2 (2005) 188 (Oct 30)
35. Westfall P.H., and Young S.S. Resampling-based Multiple Testing: Examples and Methods for P-value Adjustment (1993), John Wiley and Sons, New York
36. Westfall P.H., Tobias R.D., Rom D., Wolfinger D., and Hochberg Y. Multiple Comparisons and Multiple Tests Using the SAS System SAS Institute (1999), Cary, NC
37. Zinkernagel R.M., and Doherty P.C. Immunological surveillance against altered self components by sensitized T lymphocytes in lymphocytic choriomeningitis. Nature 251 (1974) 547